Do Stronger IPR Regimes Influence R&D Efforts? Evidence from the Indian Pharmaceutical Industry

Harishankar Jagadeesh and Subash Sasidharan
Additional contact information
Harishankar Jagadeesh: Harishankar Jagadeesh, Competition Commission of India, New Delhi.

Global Business Review, 2014, vol. 15, issue 2, 189-204

Abstract: This article is an attempt to empirically analyze the technology behaviour (R&D) of the Indian Pharmaceutical Industry (IPI) during the post Trade Related Aspects of Intellectual Property Rights (TRIPS) regime. This study is based on firm level data of 424 firms belonging to the IPI for the period 1994–2010. The empirical analysis is based on pooled cross sectional and random effects panel tobit models. The results of the study indicate that the TRIPS regime had a significant positive impact on R&D in the IPI. Firms owned by Indian groups are found to be more R&D intensive compared to stand-alone private and foreign firms. Further, export intensity and size are found to have significant impact on R&D intensity.

Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0972150914523571 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:globus:v:15:y:2014:i:2:p:189-204

DOI: 10.1177/0972150914523571

Access Statistics for this article

More articles in Global Business Review from International Management Institute
Bibliographic data for series maintained by SAGE Publications ().